Life just got more difficult for those fighting antibiotic-resistant superbugs. Researchers at McGill University have ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It ...

Introduction By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in ...

Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year.

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

Amoxicillin and penicillin are both antibiotics in the penicillin class. Alexander Fleming first discovered penicillin in 1928, and it was available to treat infections by the 1940s. Before this time, ...

Antibiotics start working immediately by rupturing the protective cell walls of harmful bacteria, but you may not feel relief ...